The most suitable choice depends on your starting skin condition, goals, and skin type, which your doctor will assess during consultation
To provide timely, complementary evidence, we conducted a comparison of tirzepatide and semaglutide in patients at low, moderate and high cardiovascular risk who were diagnosed with obesity and type 2 diabetes and subgroups with specific cardiovascular conditions
In the Surmount-OSA clinical trial, patients lost an average of 15% of their body weight using tirzepatide, which led to approximately 50% improvement in sleep apnea severity
Claims gaps alone cannot reveal why a person stopped or whether they used medication obtained outside insurance
They use real U.S
Recent data suggests the risk may be greater than previously understood, particularly for people taking Wegovy, the higher-dose version of semaglutide used for weight loss